Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment

키워드

참고문헌 (165)

1. Cooper BA, "A randomized, controlled trial of early versus late initiation of dialysis", N Engl J Med, 363, pp.609~619 (2010)
2. Collins J, "Outcomes of patients with planned initiation of hemodialysis in the IDEAL trial", Contrib Nephrol, 171, pp.1~9 (2011)
3. Harris A, "Cost-effectiveness of initiating dialysis early : a randomized controlled trial", Am J Kidney Dis, 57, pp.707~715 (2011)
4. Whalley GA, "Effect of early initiation of dialysis on cardiac structure and function : results from the echo substudy of the IDEAL trial", Am J Kidney Dis, 61, pp.262~270 (2013)
5. Korevaar JC, "When to initiate dialysis : effect of proposed US guidelines on survival", Lancet, 358, pp.1046~1050 (2001)
6. Traynor JP, "Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure", J Am Soc Nephrol, 13, pp.2125~2132 (2002)
7. Kazmi WH, "Effect of comorbidity on the increased mortality associated with early initiation of dialysis", Am J Kidney Dis, 46, pp.887~896 (2005)
8. Hwang SJ, "Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients : a national cohort study in Taiwan", Nephrol Dial Transplant, 25, pp.2616~2624 (2010)
9. Lassalle M, "Age and comorbidity may explain the paradoxical association of an early dialysis start with poor survival", Kidney Int, 77, pp.700~707 (2010)
10. Wright S, "Timing of dialysis initiation and survival in ESRD", Clin J Am Soc Nephrol, 5, pp.1828~1835 (2010)
11. Clark WF, "Association between estimated glomerular filtration rate at initiation of dialysis and mortality", CMAJ, 183, pp.47~53 (2011)
12. 장제현, "Early Start of Dialysis Has No Survival Benefit in End-Stage Renal Disease Patients", Journal of Korean Medical Science, 27(10), pp.1177~1181 (2012), 대한의학회
13. Zhang Y, "Impact of timing of initiation of dialysis on long-term prognosis of patients undergoing hemodialysis", Exp Ther Med, 16, pp.1209~1215 (2018)
14. Susantitaphong P, "GFR at initiation of dialysis and mortality in CKD : a meta-analysis", Am J Kidney Dis, 59, pp.829~840 (2012)
15. Kim DH, "The effects of vascular access types on the survival and quality of life and depression in the incident hemodialysis patients", Ren Fail, 42, pp.30~39 (2020)
16. Ozeki T, "The type of vascular access and the incidence of mortality in Japanese dialysis patients", Intern Med, 56, pp.481~485 (2017)
17. Bae E, "Autologous arteriovenous fistula is associated with superior outcomes in elderly hemodialysis patients", BMC Nephrol, 19, pp.306~ (2018)
18. Yeh LM, "The impact of vascular access types on hemodialysis patient long-term survival", Sci Rep, 9, pp.10708~ (2019)
19. Lok CE, "KDOQI clinical practice guideline for vascular access : 2019 update", Am J Kidney Dis, 75(4 Suppl 2), pp.S1~S164 (2020)
20. Shechter SM, "Timing of arteriovenous fistula creation in patients with CKD : a decision analysis", Am J Kidney Dis, 63, pp.95~103 (2014)
21. Dember LM, "The TiME Trial : a fully embedded, cluster-randomized, pragmatic trial of hemodialysis session duration", J Am Soc Nephrol, 30, pp.890~903 (2019)
22. Lowrie EG, "Effect of the hemodialysis prescription of patient morbidity : report from the National Cooperative Dialysis Study", N Engl J Med, 305, pp.1176~1181 (1981)
23. Brunelli SM, "Shorter dialysis times are associated with higher mortality among incident hemodialysis patients", Kidney Int, 77, pp.630~636 (2010)
24. Flythe JE, "Shorter length dialysis sessions are associated with increased mortality, independent of body weight", Kidney Int, 83, pp.104~113 (2013)
25. Shinzato T, "Survival in long-term haemodialysis patients : results from the annual survey of the Japanese Society for Dialysis Therapy", Nephrol Dial Transplant, 12, pp.884~888 (1997)
26. Tentori F, "Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis : results from the Dialysis Outcomes and Practice Patterns Study(DOPPS)", Nephrol Dial Transplant, 27, pp.4180~4188 (2012)
27. Shemin D, "Residual renal function and mortality risk in hemodialysis patients", Am J Kidney Dis, 38, pp.85~90 (2001)
28. Charra B, "Importance of treatment time and blood pressure control in achieving long-term survival on dialysis", Am J Nephrol, 16, pp.35~44 (1996)
29. Marshall MR, "Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients", Kidney Int, 69, pp.1229~1236 (2006)
30. Hwang HS, "Comparison of clinical outcome between twice-weekly and thrice-weekly hemodialysis in patients with residual kidney function", Medicine(Baltimore), 95, pp.e2767~ (2016)
31. Lin X, "Clinical outcome of twice-weekly hemodialysis patients with long-term dialysis vintage", Kidney Blood Press Res, 43, pp.1104~1112 (2018)
32. Sun Y, "Association of dose and frequency on the survival of patients on maintenance of hemodialysis in China : a Kaplan-Meier and cox-proportional hazard model analysis", Med Sci Monit, 24, pp.5329~5337 (2018)
33. Held PJ, "The dose of hemodialysis and patient mortality", Kidney Int, 50, pp.550~556 (1996)
34. Bloembergen WE, "Relationship of dose of hemodialysis and cause-specific mortality", Kidney Int, 50, pp.557~565 (1996)
35. Chertow GM, "Exploring the reverse J-shaped curve between urea reduction ratio and mortality", Kidney Int, 56, pp.1872~1878 (1999)
36. Wolfe RA, "Body size, dose of hemodialysis, and mortality", Am J Kidney Dis, 35, pp.80~88 (2000)
37. Port FK, "Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients", J Am Soc Nephrol, 13, pp.1061~1066 (2002)
38. Salahudeen AK, "Risk factors for higher mortality at the highest levels of spKt", V in haemodialysis patients, 2003, pp.18, 1339~1344
39. Termorshuizen F, "Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients : an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis(NECOSAD)-2", J Am Soc Nephrol, 15, pp.1061~1070 (2004)
40. Port FK, "High dialysis dose is associated with lower mortality among women but not among men", Am J Kidney Dis, 43, pp.1014~1023 (2004)
41. Ramirez SP, "Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality", Clin J Am Soc Nephrol, 7, pp.1977~1987 (2012)
42. Hong WP, "The association of dialysis adequacy, body mass index, and mortality among hemodialysis patients", BMC Nephrol, 20, pp.382~ (2019)
43. Eknoyan G, "Effect of dialysis dose and membrane flux in maintenance hemodialysis", N Engl J Med, 347, pp.2010~2019 (2002)
44. Locatelli F, "Effect of membrane permeability on survival of hemodialysis patients", J Am Soc Nephrol, 20, pp.645~654 (2009)
45. Asci G, "The impact of membrane permeability and dialysate purity on cardiovascular outcomes", J Am Soc Nephrol, 24, pp.1014~1023 (2013)
46. Ayli M, "The effect of high-flux hemodialysis on dialysis-associated amyloidosis", Ren Fail, 27, pp.31~34 (2005)
47. Chazot C, "Effect of membrane permeability on cardiovascular risk factors and β2m plasma levels in patients on long-term haemodialysis : a randomised crossover trial", Nephron, 129, pp.269~275 (2015)
48. Klemm A, "Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products(AGEs)and homocysteine metabolites", Clin Nephrol, 61, pp.191~197 (2004)
49. Kuchle C, "High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis", Am J Nephrol, 16, pp.484~488 (1996)
50. Lang SM, "Preservation of residual renal function in dialysis patients : effects of dialysis-technique-related factors", Perit Dial Int, 21, pp.52~57 (2001)
51. Li PK, "Effect of membrane permeability on inflammation and arterial stiffness : a randomized trial", Clin J Am Soc Nephrol, 5, pp.652~658 (2010)
52. Locatelli F, "Effect of high-flux dialysis on the anaemia of haemodialysis patients", Nephrol Dial Transplant, 15, pp.1399~1409 (2000)
53. Locatelli F, "Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group", Kidney Int, 50, pp.1293~1302 (1996)
54. Simon P, "Indices of adequate dialysis in patients hemodialyzed with AN 69 membrane", Kidney Int Suppl, 41, pp.S291~S295 (1993)
55. Ok E, "Mortality and cardiovascular events in online haemodiafiltration(OL-HDF)compared with highflux dialysis : results from the Turkish OL-HDF Study", Nephrol Dial Transplant, 28, pp.192~202 (2013)
56. Morena M, "Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly", Kidney Int, 91, pp.1495~1509 (2017)
57. Maduell F, "High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients", J Am Soc Nephrol, 24, pp.487~497 (2013)
58. Suwabe T, "Effect of online hemodiafiltration compared with hemodialysis on quality of life in patients with ESRD : a systematic review and meta-analysis of randomized trials", PLoS One, 13, pp.e0205037~ (2018)
59. Kantartzi K, "Can dialysis modality influence quality of life in chronic hemodialysis patients? : low-flux hemodialysis versus high-flux hemodiafiltration : a cross-over study", Ren Fail, 35, pp.216~221 (2013)
60. Karkar A, "A randomized trial on health-related patient satisfaction level with high-efficiency online hemodiafiltration versus high-flux dialysis", Blood Purif, 40, pp.84~91 (2015)
61. Mazairac AH, "Effect of hemodiafiltration on quality of life over time", Clin J Am Soc Nephrol, 8, pp.82~89 (2013)
62. Smith JR, "A randomized, single-blind, crossover trial of recovery time in high-flux hemodialysis and hemodiafiltration", Am J Kidney Dis, 69, pp.762~770 (2017)
63. Ward RA, "A comparison of on-line hemodiafiltration and high-flux hemodialysis : a prospective clinical study", J Am Soc Nephrol, 11, pp.2344~2350 (2000)
64. Ashby D, "Renal association clinical practice guideline on haemodialysis", BMC Nephrol, 20, pp.379~ (2019)
65. Lazrak HH, "Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis : a systematic review and meta-analysis", BMC Nephrol, 18, pp.187~ (2017)
66. Lim W, "Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure : a meta-analysis of randomized trials", J Am Soc Nephrol, 15, pp.3192~3206 (2004)
67. Palamaner Subash Shantha G, "Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease : systematic review and meta-analysis", PeerJ, 3, pp.e835~ (2015)
68. Borm JJ, "Heparin versus low molecular weight heparin K 2165 in chronic hemodialysis patients: a randomized cross-over study", Haemostasis, 16(Suppl 2), pp.59~68 (1986)
69. Koutsikos D, "A cross-over study of a new low molecular weight heparin(Logiparin)in hemodialysis", Int J Artif Organs, 19, pp.467~471 (1996)
70. Ryan KE, "Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis", Thromb Haemost, 66, pp.277~282 (1991)
71. Al-Saran KA, "Profile of low molecular weight tinzaparin sodium for anticoagulation during hemodialysis", Saudi J Kidney Dis Transpl, 21, pp.43~49 (2010)
72. Bramham K, "Comparison of Tinzaparin and unfractionated heparin as anticoagulation on haemodialysis : equal safety, efficacy and economical parity", Nephron Clin Pract, 110, pp.c107~c113 (2008)
73. Yang C, "Low molecular weight heparin reduces triglyceride, VLDL and cholesterol", HDL levels in hyperlipidemic diabetic patients on hemodialysis, 1998, pp.18, 384~390
74. Sabry A, "Anticoagulation therapy during haemodialysis : a comparative study between two heparin regimens", Blood Coagul Fibrinolysis, 20, pp.57~62 (2009)
75. Bambauer R, "Comparison of low molecular weight heparin and standard heparin in hemodialysis", ASAIO Trans, 36, pp.M646~M649 (1990)
76. Lord H, "Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center", Am J Nephrol, 22, pp.58~66 (2002)
77. Nurmohamed MT, "Long-term efficacy and safety of a low molecular weight heparin in chronic hemodialysis patients : a comparison with standard heparin", ASAIO Trans, 37, pp.M459~M461 (1991)
78. Saltissi D, "Comparison of low-molecular-weight heparin(enoxaparin sodium)and standard unfractionated heparin for haemodialysis anticoagulation", Nephrol Dial Transplant, 14, pp.2698~2703 (1999)
79. Schrader J, "Comparison of low molecular weight heparin to standard heparin in hemodialysis", hemofiltration, 1988, pp.33, 890~896
80. Stefoni S, "Standard heparin versus low-molecular-weight heparin : a medium-term comparison in hemodialysis", Nephron, 92, pp.589~600 (2002)
81. 김현철, "출혈 위험이 있는 혈액투석 환자에서 국소 항응고제 Futhan의 효과 - 다기관 공동 연구", Kidney Research and Clinical Practice, 23(6), pp.920~926 (2004), 대한신장학회
82. Yang JW, "Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage", Ren Fail, 31, pp.668~675 (2009)
83. Kalantar-Zadeh K, "Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis", Circulation, 119, pp.671~679 (2009)
84. Stegmayr BG, "Minimized weight gain between hemodialysis contributes to a reduced risk of death", Int J Artif Organs, 29, pp.675~680 (2006)
85. Foley RN, "Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study", Kidney Int, 62, pp.1784~1790 (2002)
86. Saran R, "Nonadherence in hemodialysis : associations with mortality, hospitalization, and practice patterns in the DOPPS", Kidney Int, 64, pp.254~262 (2003)
87. Hecking M, "Greater fluid overload and lower interdialytic weight gain are independently associated with mortality in a large international hemodialysis population", Nephrol Dial Transplant, 33, pp.1832~1842 (2018)
88. Kurita N, "Revisiting interdialytic weight gain and mortality association with serum albumin interactions : the Japanese Dialysis Outcomes and Practice Pattern Study", J Ren Nutr, 27, pp.421~429 (2017)
89. Toida T, "Relationship between hemoglobin levels corrected by interdialytic weight gain and mortality in Japanese hemodialysis patients : Miyazaki Dialysis Cohort Study", PLoS One, 12, pp.e0169117~ (2017)
90. Lee MJ, "Interdialytic weight gain and cardiovascular outcome in incident hemodialysis patients", Am J Nephrol, 39, pp.427~435 (2014)
91. Stefansson BV, "Intradialytic hypotension and risk of cardiovascular disease", Clin J Am Soc Nephrol, 9, pp.2124~2132 (2014)
92. Wong MM, "Interdialytic weight gain : trends, predictors, and associated outcomes in the International Dialysis Outcomes and Practice Patterns Study(DOPPS)", Am J Kidney Dis, 69, pp.367~379 (2017)
93. Dantas LG, "Non-adherence to haemodialysis, interdialytic weight gain and cardiovascular mortality : a cohort study", BMC Nephrol, 20, pp.402~ (2019)
94. Leggat JE Jr, "Noncompliance in hemodialysis : predictors and survival analysis", Am J Kidney Dis, 32, pp.139~145 (1998)
95. Dunlop JL, "Rationale and design of the Sodium Lowering In Dialysate(SoLID)trial : a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass", BMC Nephrol, 14, pp.149~ (2013)
96. Charra B, "Survival as an index of adequacy of dialysis", Kidney Int, 41, pp.1286~1291 (1992)
97. London GM, "Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis : follow-up of an interventional study", J Am Soc Nephrol, 12, pp.2759~2767 (2001)
98. Mominadam S, "Interdialytic blood pressure obtained by ambulatory blood pressure measurement and left ventricular structure in hypertensive hemodialysis patients", Hemodial Int, 12, pp.322~327 (2008)
99. FHN Trial Group, "In-center hemodialysis six times per week versus three times per week", N Engl J Med, 363, pp.2287~2300 (2010)
100. Culleton BF, "Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life : a randomized controlled trial", JAMA, 298, pp.1291~1299 (2007)
101. Katzarski KS, "Fluid state and blood pressure control in patients treated with long and short haemodialysis", Nephrol Dial Transplant, 14, pp.369~375 (1999)
102. Wald R, "Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis", BMC Nephrol, 13, pp.3~ (2012)
103. Chan CT, "Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis", Kidney Int, 61, pp.2235~2239 (2002)
104. Marshall MR, "Are dialysate sodium levels too high?", Semin Dial, 25, pp.277~283 (2012)
105. 김선민, "유지 혈액투석 환자에서 저나트륨 투석액의 효과", Kidney Research and Clinical Practice, 30(1), pp.53~60 (2011), 대한신장학회
106. Dunlop JL, "Low dialysate sodium levels for chronic haemodialysis", Cochrane Database Syst Rev, 1, pp.CD011204~ (2019)
107. Beduschi GC, "Effect of dialysate sodium reduction on body water volume, blood pressure, and inflammatory markers in hemodialysis patients : a prospective randomized controlled study", Ren Fail, 35, pp.742~747 (2013)
108. Boquin E, "Crossover study of the effects of different dialysate sodium concentrations in large surface area, short-term dialysis", Proc Clin Dial Transplant Forum, 7, pp.48~52 (1977)
109. Liu J, "Increasing dialysis sodium removal on arterial stiffness and left ventricular hypertrophy in hemodialysis patients", J Ren Nutr, 26, pp.38~44 (2016)
110. Akyol A, "Effects of lowered dialysate sodium on left ventricle function and brain natriuretic peptide in maintenance of hemodialysis patients", Hum Exp Toxicol, 36, pp.128~134 (2017)
111. Arramreddy R, "Individualized reduction in dialysate sodium in conventional in-center hemodialysis", Hemodial Int, 16, pp.473~480 (2012)
112. Kooman JP, "Dialysate sodium concentration and blood pressure control in haemodialysis patients", Nephrol Dial Transplant, 15, pp.554~ (2000)
113. Sayarlioglu H, "Effects of low sodium dialysate in chronic hemodialysis patients : an echocardiographic study", Ren Fail, 29, pp.143~146 (2007)
114. Zhou YL, "Effects of increasing diffusive sodium removal on blood pressure control in hemodialysis patients with optimal dry weight", Blood Purif, 35, pp.209~215 (2013)
115. Heerspink HJ, "Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis : a systematic review and meta-analysis of randomised controlled trials", Lancet, 373, pp.1009~1015 (2009)
116. Hannedouche T, "Multiphasic effects of blood pressure on survival in hemodialysis patients", Kidney Int, 90, pp.674~684 (2016)
117. Jhee JH, "The optimal blood pressure target in different dialysis populations", Sci Rep, 8, pp.14123~ (2018)
118. Van Buren PN, "Intradialytic hypertension and the association with interdialytic ambulatory blood pressure", Clin J Am Soc Nephrol, 6, pp.1684~1691 (2011)
119. Assimon MM, "A comparative study of carvedilol versus metoprolol initiation and 1-year mortality among individuals receiving maintenance hemodialysis", Am J Kidney Dis, 72, pp.337~348 (2018)
120. Agarwal R, "Dry-weight reduction in hypertensive hemodialysis patients(DRIP) : a randomized, controlled trial", Hypertension, 53, pp.500~507 (2009)
121. Zhang H, "Association of all-cause mortality with pre-dialysis systolic blood pressure and its peridialytic change in chronic hemodialysis patients", Nephrol Dial Transplant, 35, pp.1602~1608 (2020)
122. Tsujimoto Y, "Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis", Cochrane Database Syst Rev, 7, pp.CD012598~ (2019)
123. Selby NM, "Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate", Clin J Am Soc Nephrol, 1, pp.1216~1225 (2006)
124. Chesterton LJ, "Cool dialysate reduces asymptomatic intradialytic hypotension and increases baroreflex variability", Hemodial Int, 13, pp.189~196 (2009)
125. Fine A, "The protective effect of cool dialysate is dependent on patients’ predialysis temperature", Am J Kidney Dis, 28, pp.262~265 (1996)
126. Jost CM, "Effects of cooler temperature dialysate on hemodynamic stability in"problem"dialysis patients", Kidney Int, 44, pp.606~612 (1993)
127. Ayoub A, "Effect of cool temperature dialysate on the quality and patients’ perception of haemodialysis", Nephrol Dial Transplant, 19, pp.190~194 (2004)
128. Maggiore Q, "The effects of control of thermal balance on vascular stability in hemodialysis patients : results of the European randomized clinical trial", Am J Kidney Dis, 40, pp.280~290 (2002)
129. Jefferies HJ, "Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability", Blood Purif, 32, pp.63~68 (2011)
130. Cruz DN, "Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension", Am J Kidney Dis, 33, pp.920~926 (1999)
131. Azar AT, "Effect of dialysate temperature on hemodynamic stability among hemodialysis patients", Saudi J Kidney Dis Transpl, 20, pp.596~603 (2009)
132. Hegbrant J, "Delayed decrease in plasma levels of atrial natriuretic peptide during cold hemodialysis", Nephron, 68, pp.427~432 (1994)
133. Owen WF Jr, "The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis", N Engl J Med, 329, pp.1001~1006 (1993)
134. Hakim RM, "Effects of dose of dialysis on morbidity and mortality", Am J Kidney Dis, 23, pp.661~669 (1994)
135. Parker TF 3rd, "Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis", Am J Kidney Dis, 23, pp.670~680 (1994)
136. Collins AJ, "Urea index and other predictors of hemodialysis patient survival", Am J Kidney Dis, 23, pp.272~282 (1994)
137. Thomas A, "The frequency of routine blood sampling and patient outcomes among maintenance hemodialysis recipients", Am J Kidney Dis, 75, pp.471~479 (2020)
138. Hemodialysis Adequacy 2006 Work Group, "Clinical practice guidelines for hemodialysis adequacy, update 2006", Am J Kidney Dis, 48(Suppl 1), pp.S2~S90 (2006)
139. Tattersall J, "EBPG guideline on dialysis strategies", Nephrol Dial Transplant, 22(Suppl 2), pp.ii5~ii21 (2007)
140. Drueke TB, "Summary of the KDIGO guideline on anemia and comment : reading between the(guide)line(s)", Kidney Int, 82, pp.952~960 (2012)
141. Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Work Group, "KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)", Kidney Int Suppl, 113, pp.S1~S130 (2009)
142. Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Update Work Group, "KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)", Kidney Int Suppl(2011), 7, pp.1~59 (2017)
143. Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C Work Group, "KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease", Kidney Int Suppl(2011), 8, pp.91~165 (2018)
144. Jardine M, "Kidney Health Australia: Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units", Nephrology(Carlton), 24, pp.951~957 (2019)
145. Garthwaite E, "Clinical practice guideline management of blood borne viruses within the haemodialysis unit", BMC Nephrol, 20, pp.388~ (2019)
146. Foote C, "Survival outcomes of supportive care versus dialysis therapies for elderly patients with end-stage kidney disease: a systematic review and meta-analysis", Nephrology(Carlton), 21, pp.241~253 (2016)
147. Wongrakpanich S, "Dialysis therapy and conservative management of advanced chronic kidney disease in the elderly : a systematic review", Nephron, 137, pp.178~189 (2017)
148. Smith C, "Choosing not to dialyse : evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure", Nephron Clin Pract, 95, pp.c40~c46 (2003)
149. Joly D, "Octogenarians reaching end-stage renal disease : cohort study of decision-making and clinical outcomes", J Am Soc Nephrol, 14, pp.1012~1021 (2003)
150. Murtagh FE, "Dialysis or not? : a comparative survival study of patients over 75 years with chronic kidney disease stage 5", Nephrol Dial Transplant, 22, pp.1955~1962 (2007)
151. Carson RC, "Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease?", Clin J Am Soc Nephrol, 4, pp.1611~1619 (2009)
152. Brown MA, "CKD in elderly patients managed without dialysis : survival, symptoms, and quality of life", Clin J Am Soc Nephrol, 10, pp.260~268 (2015)
153. Raman M, "Outcomes in dialysis versus conservative care for older patients : a prospective cohort analysis of stage 5 chronic kidney disease", PLoS One, 13, pp.e0206469~ (2018)
154. van Loon IN, "Quality of life after the initiation of dialysis or maximal conservative management in elderly patients : a longitudinal analysis of the Geriatric assessment in OLder patients starting Dialysis(GOLD)study", BMC Nephrol, 20, pp.108~ (2019)
155. Verberne WR, "Comparative survival among older adults with advanced kidney disease managed conservatively versus with dialysis", Clin J Am Soc Nephrol, 11, pp.633~640 (2016)
156. Reindl-Schwaighofer R, "Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5", PLoS One, 12, pp.e0181345~ (2017)
157. Tam-Tham H, "Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not", Kidney Int, 94, pp.582~588 (2018)
158. Pyart R, "Exploring the choices and outcomes of older patients with advanced kidney disease", PLoS One, 15, pp.e0234309~ (2020)
159. Tam-Tham H, "Association of initiation of dialysis with hospital length of stay and intensity of care in older adults with kidney failure", JAMA Netw Open, 3, pp.e200222~ (2020)
160. Kaur A, "Hemodialysis for infants, children, and adolescents", Hemodial Int, 18, pp.573~582 (2014)
161. Chand DH, "Dialysis in children and adolescents : the pediatric nephrology perspective", Am J Kidney Dis, 69, pp.278~286 (2017)
162. Salerno AE, "American Society of Pediatric Nephrology Position Paper : standard resources required for a pediatric nephrology practice", J Pediatr, 174, pp.254~259 (2016)
163. Jones L, "Pediatric Dialysis", pp.53~72 (2012), Springer
164. The Renal Team: A Multi-Professional Renal Workforce Plan for Adults and Children with Renal Disease, "Royal College of Nursing (Great Britain)", British Renal Society, ~ (2002)
165. "BCNU Position Statement on Mandated Nurse–Patient Ratios" (2011)[URL]

관련 논문AI추천